chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a Nurse refers to an unspecified number of patients of unkonwn age and gender. On an unknown date the patients were vaccinated with PROQUAD (Merck) (Lot# K018142, Expiry:10-APR-2016), 0.5 ml, subcutaneous, which was improperly stored. No adverse effects were reported. No product quality complaint was involved. This is one of the several reports linked with the same reporter link. No additional information provided. Additional information has been requested.
Still having symptoms; Severe joint pain; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION COMPLICATION (Still having symptoms) and ARTHRALGIA (Severe joint pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced ARTHRALGIA (Severe joint pain). On an unknown date, the patient experienced VACCINATION COMPLICATION (Still having symptoms). At the time of the report, VACCINATION COMPLICATION (Still having symptoms) and ARTHRALGIA (Severe joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication included Tylenol.
Pt. complains of swelling and redness in L extremity with pain that radiates to breast area.
Felt lightheaded and disoriented. Went to emergency clinic and got blood sugar, blood pressure checked. My first 3 shots were Phyzier and this one Moderna
I experienced a delayed menstrual cycle after both doses of vaccine. 10 days delayed after dose one and 4 days delayed after dose two. I'm normally very regular and never late.
16 hours after receiving my 2nd Covid 19 vac shot, I woke up and my body felt like it was on fire, my eyes were burning and had a bad headache. I took 2 Advils and tried to fall back to sleep. Six hours later my fever and headache returned along with the chills and body aches.  I took 2 more Advil and waited an hour and the headache went away. It took about a day and a half before before the side affects subsided.
Date the vial was initially stored in the refrigerator on 25Aug2022, Date(s) of administration of vaccine on 28Sep2022; No adverse event; 1 dose of Moderna Covid-19 vaccine (Monovalent) was administered after the beyond use date of 21Sep2022.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1 dose of Moderna Covid-19 vaccine (Monovalent) was administered after the beyond use date of 21Sep2022.), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 25Aug2022, Date(s) of administration of vaccine on 28Sep2022) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 082B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Sep-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (1 dose of Moderna Covid-19 vaccine (Monovalent) was administered after the beyond use date of 21Sep2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 25Aug2022, Date(s) of administration of vaccine on 28Sep2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (1 dose of Moderna Covid-19 vaccine (Monovalent) was administered after the beyond use date of 21Sep2022.), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 25Aug2022, Date(s) of administration of vaccine on 28Sep2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (1 dose of Moderna Covid-19 vaccine (Monovalent) was administered after the beyond use date of 21Sep2022.) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 25Aug2022, Date(s) of administration of vaccine on 28Sep2022).    No concomitant medication information was provided. The patient received 1 dose of the moderna covid-19 vaccine with monovalent product. Vial size was 5.5ml. On 25 Aug 2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. No treatment medication information was provided.
fever temp >104;severe h/a, abd pain;nausea x 3 days;
pt recvd vax 15APR95 & approx 1 wk post vax pt exp aches & pains in joints particularly in one hip;sx are somewhat better but persist;
The patient had a red, splotchy rash on legs that mother noticed around 4:30 PM on date vaccine was given.  She stated no difficulty breathing or distress.  She stated rash did not progress to other parts of body that day (2/23/2016). Mother took child to daycare the next day (2/24/2016).  Daycare called around lunch and said rash was back and had progressed down legs to feet and some on arms.  No other apparent distress was noted.  Mother was at ED with child waiting to be seen.
Localized erythemic wheal appeared on (R) thigh within 10 minutes, prior to leaving the clinic. Ice pack was applied.
Day of VacinnationSyncopal episode, hypertension, dizzy, nausea, improved somewhat after 40 minutes, no other treatment provided other than recumbant position and cold compress. Day 1 feverish and light-headed, took ibuprofen Day 2 nausea off and on all day. Day 3 continue to be light-headed, periods of dizziness, and "foggy" which has continued off and on to present.
Flu-like symptoms; Shaking chills; Aches; Fell asleep and woke up feeling fine; Chills; Low fever; Joint pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Oct-2021 and was forwarded to Moderna on 23-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), TREMOR (Shaking chills), PAIN (Aches), SOMNOLENCE (Fell asleep and woke up feeling fine) and CHILLS (Chills) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), TREMOR (Shaking chills), PAIN (Aches), SOMNOLENCE (Fell asleep and woke up feeling fine), CHILLS (Chills), PYREXIA (Low fever) and ARTHRALGIA (Joint pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. On 03-Apr-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms), TREMOR (Shaking chills), PAIN (Aches), CHILLS (Chills), PYREXIA (Low fever) and ARTHRALGIA (Joint pain) had resolved. At the time of the report, SOMNOLENCE (Fell asleep and woke up feeling fine) had resolved.            No concomitant medications are provided .   This case was linked to MOD-2021-362300 (Patient Link).
By late afternoon my arm started hurting really bad.  Within 2 hours excruciating pain from top of shoulder to elbow.  Called Dr to be on safe side, said to take pain medication.  Took Hydrocod-Acetami 5-325 mg every 5 hours 3 times.  Made the pain tolerable but on a scale of 10 still a 6.  By early morning was able to move my arm partially, and by noon more mobility.  Still sore to move but more like "I just got a shot" pain.  One dose of Tramadol this morning at 7.  Followed by 400 mg Advil around 11, nothing else.  Will probaby take 400 mg Advil at bedtime.  Long nap morning and afternoon today.  I have NEVER experienced any pain of this kind.  I could not undress myself or pull up my pants.  The pain just didn't let down.  It felt like a tourniquet on my arm and just throbbing
Pt developed bilateral thigh cellulitis, right more than left. Temperature of 100.6F. The right thigh was 7cm X 3cm and left thigh was 2 1/2cm X 1 1/2cm area under cellulitis with firmness, not fluctuant. No TTP.
hives: treated with benadryl 50mg IM; improved. Caution on driving due to benadryl.
Patient passed out a few seconds after an injection, landing on his back and head on the floor. While unconscious, both his arms became tightly clenched on his chest. He regained consciousness and felt woozy. The episode lasted less than 40 seconds.
Dizziness, NauseaVomiting, TINGLING LEFT FOOT, BURNING AT INJECTION SITE. Employee monitored 1:1 and vitals taken q 5 minutes as follows: 13:25p-109, 13:35pm- 119/77, 1340 pm-121/74, 13:45 pm- 110/73, 1400pm- 109/71. Patient stated feeling better and wanted to go home. BP taken at 14:58= 106/72. Employee left Vaccination clinic ambulatory at 15:00 pm.
pt states that several days p/vax pt began having scalp itching which progressed, 1wk later to rash on chest & eventually to entire body;exfoliation of skin, rash on skin & swelling of eyes cont as of 18MAR99;MD dx as acne rosacea;
Feeling hot; had like a hard hard ball; This spontaneous case was reported by a physician and describes the occurrence of FEELING HOT (Feeling hot) and VACCINATION SITE INDURATION (had like a hard hard ball) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced FEELING HOT (Feeling hot) and VACCINATION SITE INDURATION (had like a hard hard ball). At the time of the report, FEELING HOT (Feeling hot) outcome was unknown and VACCINATION SITE INDURATION (had like a hard hard ball) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication information was provided. No treatment product information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up information was received from 11-May-2021, event outcome was updated.
No adverse event; Patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 19-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 004M21A) for COVID-19 prophylaxis.     It was unknown if patient had allergies to medication, foods and other products.  It was unknow if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown.     On 20-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine).    No concomitant medications were reported. Anatomical location of administration was reported as left. Expired Moderna vaccine had been given to 21 patients. The reporter explained that the vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergone any temperature excursion. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received contains updated reporter details
Eye irritation; vaccine splash into their eye; vaccine splash into their eye; This non-serious case was reported by a nurse via sales rep and described the occurrence of eye irritation in a 20-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 20-JUL-2023, the patient received Menveo. On 20-JUL-2023, less than a day after receiving Menveo, the patient experienced eye irritation (Verbatim: Eye irritation), occupational exposure while administering product (Verbatim: vaccine splash into their eye) and exposure via eye contact (Verbatim: vaccine splash into their eye). On 21-JUL-2023, the outcome of the eye irritation was resolved (duration 1 day). The outcome of the occupational exposure while administering product and exposure via eye contact were unknown.   The reporter considered the eye irritation to be related to Menveo.     The company considered the eye irritation to be related to Menveo.   Additional Information: GSK Receipt Date: 21-JUL-2023 The reporter stated that the medical assistant administering the vaccine to the patient had vaccine splash into their eye. Unsure exactly how that occurred as it was reported by the supervisor to GSK. Supervisor stated employee flushed their eye due to irritation and was now just fine with no ongoing irritation or symptoms. The reporter stated that the event was eye exposure/contact with Menveo by a health care provider, which led to occupational exposure while administering product and exposure via eye contact. The reporter did not consent to follow up.
Red, hot slightly itchy rash at the site of injection that developed just under 6 days from the vaccine date. The rash was about 1.5 inches around
no adverse event; Product preparation error; This spontaneous report was received from medical assistant and refers to a 4-year-old female patient. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 24-AUG-2023, the patient received a dose with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, 0.5 milliliter, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided), along with of 0.5 ml (Frequency: twice) dose 1 of suspect Diphtheria/Tetanus/5 Hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine of standard strength suspension for injection (lot: UJ8768A, Expiry date: 19-Mar-2024) via intramuscular route in left administration site for Immunization (product preparation error). Concurrently with no reported adverse event.
I had my vaccination on 04/02/2022. I tested COVID-19 Positive on 07/20/2022. I had symptoms to include headache sluggish body aches and I started to have a low-grade fever. I am a heart patient and my heart was beating fast at night. I went to the emergency room the following day and I was prescribed Paxlovid. I presently feel better but still have lingering symptoms regarding my heart. I am being monitored with my cardiologist.
21SEP PM arm, warm, achy, felt chilled;no documented temp;23SEP hives, hoarse voice, angioedema lt arm/hand;
Type of Flus shot administered is not known to me.  Patient reports episode of brain fog and fatigue as well as brief episode of fever, chills and sweats beginning a few hours after sot and lasting less than 12 hours. Patient requested this be reported.
As with the initial vaccine, the booster I recently received activated a shingles outbreak within days of the shot.  This should be noted in the records.  I have spoken with others like myself, who already had shingles for years.  Several reported the same side effect to me.  PLEASE TAKE THIS SERIOUSLY AND NOTE IT!   I filed this same complaint when I got the first shot, but no one acknowledged it as being researched.  It appears any possible negative side effects, that aren't life threatening, are being swept under the rug so as not to discourage others from getting the vaccine.  I will continue to spread this news to all medical people I am treated by, as well as all friends and family.  This needs to be looked into!!!!!
Arm hurts; Nausea; Tired; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Apr2021(at the age of 53-year-old) as a dose number unknown, single for COVID-19 immunization. Relevant medical history was not reported. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  On an unknown date in 2021 the patient experienced arm hurts, nausea, tired and headache. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm hurts, nausea, tired and headache was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Follow-up (18Aug2021) Amendment: This follow-up report was submitted to amend previously reported information: Regulatory Authority added as country in the patient information field, Relevant medical history was not reported was added in narrative, Event onset date as added as 2021. Closer sentence No follow-up attempts are possible; information about lot/batch number cannot be obtained' was updated.
10:00pm day of injection started shivering (continued most of night).   12:00am up with intense headache 2am woke up from shivering - put on another sweatshirt 4am woke up.  pool of sweat.  undressed and got rid of heating blanket 5am woke up with foggy head, headache, nausea.  up to use bathroom and almost fainted on way back to bed. 6am feverish 8am headache bad.  decide to get up. take tylenol.  stomach feels raw.  pain in armpit of injection arm,  realize its a swollen lymph node. Feel miserable all morning....fever of 101.5 at 10am (only time I took it).  armpit pain gets increasing worse throughout the morning. Feeling better (but very tired) by afternoon.  Go to bed really early. Next morning feel much better, armpit pain not as bad.  side of neck now swollen and can feel lymph node.  I am an extremely healthy, fit woman who takes no meds and has never had a reaction to any vaccine before.  This one really through me for a loop!
The night of her Vaccine, she had a seizure that seemed to be from a fever. Then she had 7 more seizures in the next 7 days. As of now she is on medication in case it is epilepsy. Hasn't been confirmed that this is the cause, but the CDC website lists it as a possible side effect.
received expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 25-year-old female patient who received HBV (Engerix B) (batch number 5L27A, expiry date 11th February 2022) for prophylaxis.   On 30th March 2022, the patient received the 1st dose of Engerix B. On 30th March 2022, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 30-MAR-2022 Reporter's Comment: The patient received an Engerix-B expired dose. The reporter consented to follow up. The reporter was working at home. Hence, requested follow-Up by fax.
A spontaneous report was received from a 15 year old female patient who on 30-AUG-2010 received her first dose of GARDASIL (route and lot number not provided). The patient was taking "all kinds of medication" concomitantly. She has an allergy to "Zomec". The patient reported that she developed cancer after her first dose of GARDASIL. In late September 2011, she received her second dose of GARDASIL and in October 2012 she received the third dose. Since then (exact onset date not specified), she had anxiety, chronic migraines, fatigue syndrome and nausea. The patient sought unspecified medical attention. The outcome of the events were unknown. The patient stated she was seeking to proceed with legal action. Upon internal review, cancer was considered medically significant. Additional information is not expected as the patient provided no contact information and disconnected the call.
initial presentation for fall w/ rib fx, hemo/PTX. developed symptomatic covid symptoms, fevers, PNA,
This spontaneous report was received from a pharmacist refers to a 65 year old female patient. No pertinent medical history was reported. On 27-SEP-2014, the patient was vaccinated with PNEUMOVAX23 1 injection, once, in left arm (lot # J009827 and expiration date was 10-AUG-2014). Concomitant medications was not reported. On 27-SEP-2014, she was accidentally gave an expired PNEUMOVAX23. She did not have any complaints when she left the pharmacy. It was unknown if there was any relevant laboratory data. As of 27-SEP-2014, it was unknown if she will receive PNEUMOVAX23 again. The outcome of giving the expired vaccine was unknown but she did not have any complaints when she left the pharmacy. The pharmacist stated that the patient was a walk-in and not referred by a physician. Additional information is not expected.
patient was nervous prior to injection, received dose, felt a little nauseous but had water bottle on hand so had patient remain sitting in immunization room and to breathe normally. after 10 minutes patient stated she was feeling better and was able to move to sitting aware to complete remainder of observation period. after 10 minutes patient stated her throat felt itchy and a little hard to swallow, otherwise no other symptoms or side effects. patient was provided a dose of Benadryl and remain seated for further observation. after 10 minutes patient stated she felt better and stated she think she might have overreacted. patient was reassessed for any other symptoms, denied any and was able to leave
Started 6/17/03, worse 6/18/03. Redness; swelling; fever; left upper arm. Given Augmentin 250 mg BID; advised mother to apply warm washcloth to affected area; call office tomorrow if no change or worse.
covid vaccine breakthrough case  dose 1 Pfizer 8/16/21  EW0173 dose 2 Pfizer 9/7/21  EW0183
Spotted rash around vaccination site on left thigh. Looks like a red around the site. Does not bother him. No itching, no pain, Not warm/or tender to the touch, no fever.
On day of vaccination, about 3-4 hours later, felt Hot/cold, but no fever. The next day, did not feel herself. Complained of head and hands shaking, neck pain, and headaches. Seen at ER on same day.